Atlas Trials

The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II

Clinical trial NCT03947879 · UNKNOWN

Trial details

NCT number
NCT03947879
Sponsor
Hawaii Pacific Health
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2019-05-01
Primary completion
2021-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.